Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Trial details
- Registry ID
- NCT06953869
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric InsomniaNCT06953869 | Vanda Pharmaceuticals | Phase 3 | Recruiting | 2027-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |